dapagliflozin/linagliptin (IN-C009) / Korea Kolmar  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dapagliflozin/linagliptin (IN-C009) / Korea Kolmar
NCT05066516: The Pharmacokinetics, Safety and Tolerability of IN-C009 in Healthy Subjects

Completed
1
48
RoW
FCDP, dapagliflozin 10mg/linagliptin 5 mg or co-administration of a single dose of dapagliflozin and linagliptin
Korea University Anam Hospital
Diabetes Mellitus
08/20
10/20

Download Options